Natalie Solis, NP
Family · Florence, AZNPI 1063190072
Payments from drug & device makers
Across 11 payments — averaging $20.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$40
- Teva Pharmaceuticals USA, Inc.$36
- UCB, Inc.$31
- Neurocrine Biosciences, Inc.$23
- Astellas Pharma US Inc$22
- Exact Sciences$21
- plus $51 from 3 others
What the payments were for
- Food & beverage$223100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| UCB, Inc. | 1 | $31 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $22 |
| Exact Sciences | 1 | $21 |
| Novo Nordisk | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Merck | 1 | $16 |
How this compares
$223 in reported general payments places this provider in the 40th percentile of 4,119 family providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 17 | $16,688 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $1,253 |
| Atorvastatin Calcium | 114 | $1,243 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $892 |
| Gabapentin | 46 | $733 |
| Losartan Potassium | 69 | $626 |
| Clobetasol Propionate | 15 | $621 |
| Levothyroxine Sodium | 72 | $438 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 33 | $409 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 45 | $370 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 41 | $335 |
| Fluticasone Propionate | 29 | $330 |
| Metoprolol Succinate | 21 | $319 |
| Lisinopril | 51 | $311 |
| Amlodipine Besylate | 62 | $309 |
Paid to pharmacies, not to this prescriber.
Other family in Florence
- Sharon MagalonaMesa$449K
- Angela GoldenMunds Park$378K
- Kimberly HallaPhoenix$332K
- Kaitlyn LouchheimScottsdale$208K
- Rebecca McCollaumMesa$149K
- Susan SarabiaSun City West$114K
- Lindsay CarterTucson$108K
- Audrey StevensonPhoenix$83K
- Keith MorsePrescott$83K
- Celeste FineGilbert$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.